Member Info for Laura2022

Badsterman

Posts: 767

Price: 1.25

Hold

RE: Money for 201 dealToday 13:48

Very pragmatic presentation,

Focus on the commercial, Inaphaea profitable in H1 2025, cashburn tightened, timeclock on 201 with updates due.

Identifying and repurposing clinical stage failures, US push, want drugs with multiple disease indications and more evaluations.

That's a lot of strands of work, he also stated he'll buy shares and seemed very confident.

Announcements to follow before year end...

👍 from me and the market (+17%)

Thanks

When i emailed the CEO I was happy with his reply and everything he said has proven to be correct with the fullness of time

Remember the email you wanted me to divulge when you were in one of your U turns

You're getting as desperate as Porky and grainger now uncanny

A far cry from your bullishness just 4 weeks ago

:)

"And investments"

Namely M and A activity

Maybe watch the Q and A once it's on the VAL website

Yes ...we can read

may include working capital, capital expenditures, research and development expenditures and the acquisitions of new technologies and investments 

Nope...you're not in and have been caught out ...

As for EUDA they're not going to break NDA by publicly naming the merger until done are they ?????? As the commercial terms would be sensitive

 (“EUDA” or the “Company”) (NASDAQ: EUDA), a Singapore-based digital health platform that aims to make healthcare more affordable, accessible, and improve the patient experience by delivering enhanced outcomes through personalized healthcare, today announced that it has signed a letter of intent dated October 4, 2023, with respect to the proposed merger with TheoremRx Inc. (“TheoremRx”), a private U.S.-based company focused on the development of new treatments with safe administration, low toxicity, and a high potential for polypharmacy usage to benefit patients suffering from cancer and women’s health conditions.

Not a problem

It doesn't affect you uncanny as you're not in after your 4th u turn

Grainger14

Posts: 112

Price: 1.25

No Opinion

TradingToday 11:59

The trading this morning says it all...all time low.

Only a fool would invest in here...

VAL then did 70% on 9mln volume

Poor Grainger

Jimbo

See discussion over weekend re: EUDA of that helps

GB

And EUDA raised this $100mln just a few days ago

With this monet now it allows the THX VAL deal which triggers up to $50mln to VAL and $6mln to PYC

The world is moving towards A.I in medicine..can only help PYC

https://www.tempus.com/?srsltid=AfmBOorJsoQQ2-8WjD3WxhqiO-ZKjHOqcgvLZHfhG8Gwa_VvUgo0O5fs

LONDON - Oct. 21, 2024 - Avacta Therapeutics (AIM: AVCT), a life sciences company developing next generation peptide drug conjugates (PDC) targeting powerful anti-tumor payloads directly to the tumor, today announces the initiation of an artificial intelligence (AI)-focused collaboration with Tempus AI, Inc. (Nasdaq: TEM), a technology company leading the adoption of artificial intelligence to advance precision medicine and patient care

Porky

Youve not posted on GDR yet today ans they've had a very strange RNS

Yet you've found time to post 5 times here

The Physiomics plc team is heading to the EORTC-NCI-AACR Symposium in Barcelona from 23-25 October! 🌍 We’re excited to connect with R&D leaders in oncology to discuss the significance of Model-Informe

Thanks Ralph

Really feels like things are knitting together under Pete

The event will require prior registration, with registration links and full details available on the Company's website on https://www.valirx.com/contact

The webinar will be available to view on demand through our website after the event

Oxford BioDynamics Plc

2,851 followers

1w

Great insights from Goodbody Wellness Ltd on how #EpiSwitchPSE brings peace of mind with 94% accuracy. Full article here: bit.ly/3ZVNibc. #ProstateCancer #MensHealth

PYC stand to get up to £6mln versus current £1 4mln and record revenues booked for H2 already of £600k + got £600k in cash

VAL success good FOR PYC